Rothschild & Co Wealth Management UK Ltd - OPIANT PHARMACEUTICALS INC ownership

OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 1 filers reported holding OPIANT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rothschild & Co Wealth Management UK Ltd ownership history of OPIANT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$37,000
+85.0%
1,4190.0%0.00%
Q2 2021$20,000
+33.3%
1,4190.0%0.00%
Q1 2021$15,000
+36.4%
1,4190.0%0.00%
Q4 2020$11,0000.0%1,4190.0%0.00%
Q3 2020$11,000
-15.4%
1,4190.0%0.00%
Q2 2020$13,000
-7.1%
1,4190.0%0.00%
Q1 2020$14,0001,4190.00%
Other shareholders
OPIANT PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 210,000$2,518,0005.80%
APIS CAPITAL ADVISORS, LLC 196,000$2,350,0002.65%
Stonepine Capital Management, LLC 152,278$1,826,0000.85%
Parkman Healthcare Partners LLC 75,632$907,0000.33%
PERRITT CAPITAL MANAGEMENT INC 30,500$366,0000.22%
ESSEX INVESTMENT MANAGEMENT CO LLC 50,405$604,0000.10%
ACADIAN ASSET MANAGEMENT LLC 126,978$1,523,0000.01%
Trexquant Investment LP 12,219$147,0000.01%
Renaissance Technologies 193,415$2,319,0000.00%
TWO SIGMA ADVISERS, LP 74,400$892,0000.00%
View complete list of OPIANT PHARMACEUTICALS INC shareholders